Oligomerix Presents Data from IND-Enabling Studies on Clinical Candidate at Clinical Trials on Alzheimer’s Disease (CTAD) and Neuroscience 2022 Meetings
Home > News > Oligomerix Presents Data from IND-Enabling Studies on Clinical Candidate at Clinical Trials on Alzheimer's Disease (CTAD) and Neuroscience 2022 Meetings
Oligomerix > News > Oligomerix Presents Data from IND-Enabling Studies on Clinical Candidate at Clinical Trials on Alzheimer’s Disease (CTAD) and Neuroscience 2022 Meetings
Oligomerix Presents Data from IND-Enabling Studies on Clinical Candidate at Clinical Trials on Alzheimer’s Disease (CTAD) and Neuroscience 2022 Meetings
By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.Ok
